Literature DB >> 26652229

Late-onset polyglucosan body myopathy in five patients with a homozygous mutation in GYG1.

H Orhan Akman1, Yavuz Aykit2, Ozge Ceren Amuk2, Edoardo Malfatti3, Norma B Romero3, Maria Antonietta Maioli4, Rachele Piras4, Salvatore DiMauro2, Gianni Marrosu4.   

Abstract

Five Sardinian patients presented in their 5th or 6th decade with progressive limb girdle muscle weakness but their muscle biopsies showed vacuolar myopathy. The more or less abundant subsarcolemmal and intermyofibrillar vacuoles showed intense, partially α-amylase resistant, PAS-positive deposits consistent with polyglucosan. The recent description of late-onset polyglucosan myopathy has prompted us to find new genetic defects in the gene (GYG1) encoding glycogenin-1, the crucial primer enzyme of glycogen synthesis in muscle. We found a single homozygous intronic mutation harbored by five patients, who, except for two siblings, appear to be unrelated but all five live in central or south Sardinian villages.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  GYG1; Glycogenin deficiency; Glycogenosis; Polyglucosan myopathy

Mesh:

Substances:

Year:  2015        PMID: 26652229      PMCID: PMC4724519          DOI: 10.1016/j.nmd.2015.10.012

Source DB:  PubMed          Journal:  Neuromuscul Disord        ISSN: 0960-8966            Impact factor:   4.296


  21 in total

1.  Longitudinal follow-up and muscle MRI pattern of two siblings with polyglucosan body myopathy due to glycogenin-1 mutation.

Authors:  Irene Colombo; Serena Pagliarani; Silvia Testolin; Claudia Maria Cinnante; Gigliola Fagiolari; Patrizia Ciscato; Andreina Bordoni; Francesco Fortunato; Francesca Magri; Stefano Carlo Previtali; Daniele Velardo; Monica Sciacco; Giacomo Pietro Comi; Maurizio Moggio
Journal:  J Neurol Neurosurg Psychiatry       Date:  2015-07-22       Impact factor: 10.154

2.  Juvenile-onset permanent weakness in muscle phosphofructokinase deficiency.

Authors:  Edoardo Malfatti; Nazha Birouk; Norma B Romero; Monique Piraud; François M Petit; Jean-Yves Hogrel; Pascal Laforêt
Journal:  J Neurol Sci       Date:  2012-02-23       Impact factor: 3.181

3.  Glycogenin-1 deficiency and inactivated priming of glycogen synthesis.

Authors:  Ali-Reza Moslemi; Christopher Lindberg; Johanna Nilsson; Homa Tajsharghi; Bert Andersson; Anders Oldfors
Journal:  N Engl J Med       Date:  2010-04-01       Impact factor: 91.245

4.  A distinct form of adult polyglucosan body disease with massive involvement of central and peripheral neuronal processes and astrocytes: a report of four cases and a review of the occurrence of polyglucosan bodies in other conditions such as Lafora's disease and normal ageing.

Authors:  Y Robitaille; S Carpenter; G Karpati; S D DiMauro
Journal:  Brain       Date:  1980-06       Impact factor: 13.501

5.  Surprises of genetic engineering: a possible model of polyglucosan body disease.

Authors:  N Raben; M Danon; N Lu; E Lee; L Shliselfeld; A V Skurat; P J Roach; J C Lawrence ; O Musumeci; S Shanske; S DiMauro; P Plotz
Journal:  Neurology       Date:  2001-06-26       Impact factor: 9.910

6.  Adult polyglucosan body disease: Natural History and Key Magnetic Resonance Imaging Findings.

Authors:  Fanny Mochel; Raphael Schiffmann; Marjan E Steenweg; Hasan O Akman; Mary Wallace; Frédéric Sedel; Pascal Laforêt; Richard Levy; J Michael Powers; Sophie Demeret; Thierry Maisonobe; Roseline Froissart; Bruno Barcelos Da Nobrega; Brent L Fogel; Marvin R Natowicz; Catherine Lubetzki; Alexandra Durr; Alexis Brice; Hanna Rosenmann; Varda Barash; Or Kakhlon; J Moshe Gomori; Marjo S van der Knaap; Alexander Lossos
Journal:  Ann Neurol       Date:  2012-09       Impact factor: 10.422

7.  Muscle pathology and whole-body MRI in a polyglucosan myopathy associated with a novel glycogenin-1 mutation.

Authors:  Sushan Luo; Wenhua Zhu; Dongyue Yue; Jie Lin; Yin Wang; Zhen Zhu; Wenjuan Qiu; Jiahong Lu; Carola Hedberg-Oldfors; Anders Oldfors; Chongbo Zhao
Journal:  Neuromuscul Disord       Date:  2015-07-15       Impact factor: 4.296

8.  Glycogen synthase (GYS1) mutation causes a novel skeletal muscle glycogenosis.

Authors:  Molly E McCue; Stephanie J Valberg; Michael B Miller; Claire Wade; Salvatore DiMauro; Hasan O Akman; James R Mickelson
Journal:  Genomics       Date:  2008-03-20       Impact factor: 5.736

9.  Type IV glycogenosis (amylopectinosis). Light and electron microscopic observations.

Authors:  S S Schochet; W F McCormick; H Zellweger
Journal:  Arch Pathol       Date:  1970-10

10.  Immunodeficiency, autoinflammation and amylopectinosis in humans with inherited HOIL-1 and LUBAC deficiency.

Authors:  Bertrand Boisson; Emmanuel Laplantine; Carolina Prando; Silvia Giliani; Elisabeth Israelsson; Zhaohui Xu; Avinash Abhyankar; Laura Israël; Giraldina Trevejo-Nunez; Dusan Bogunovic; Alma-Martina Cepika; Donna MacDuff; Maya Chrabieh; Marjorie Hubeau; Fanny Bajolle; Marianne Debré; Evelina Mazzolari; Donatella Vairo; Fabrice Agou; Herbert W Virgin; Xavier Bossuyt; Caroline Rambaud; Fabio Facchetti; Damien Bonnet; Pierre Quartier; Jean-Christophe Fournet; Virginia Pascual; Damien Chaussabel; Luigi D Notarangelo; Anne Puel; Alain Israël; Jean-Laurent Casanova; Capucine Picard
Journal:  Nat Immunol       Date:  2012-10-28       Impact factor: 25.606

View more
  9 in total

Review 1.  Myopathies Related to Glycogen Metabolism Disorders.

Authors:  Mark A Tarnopolsky
Journal:  Neurotherapeutics       Date:  2018-10       Impact factor: 7.620

Review 2.  Update on polyglucosan storage diseases.

Authors:  Giovanna Cenacchi; V Papa; R Costa; V Pegoraro; R Marozzo; M Fanin; C Angelini
Journal:  Virchows Arch       Date:  2019-07-30       Impact factor: 4.064

3.  Start codon mutation of GYG1 causing late-onset polyglucosan body myopathy with nemaline rods.

Authors:  Giorgio Tasca; Fabiana Fattori; Mauro Monforte; Carola Hedberg-Oldfors; Mario Sabatelli; Bjarne Udd; Renata Boldrini; Enrico Bertini; Enzo Ricci; Anders Oldfors
Journal:  J Neurol       Date:  2016-08-20       Impact factor: 4.849

Review 4.  Skeletal muscle disorders of glycogenolysis and glycolysis.

Authors:  Richard Godfrey; Ros Quinlivan
Journal:  Nat Rev Neurol       Date:  2016-05-27       Impact factor: 42.937

5.  251st ENMC international workshop: Polyglucosan storage myopathies 13-15 December 2019, Hoofddorp, the Netherlands.

Authors:  Pascal Laforêt; Anders Oldfors; Edoardo Malfatti; John Vissing
Journal:  Neuromuscul Disord       Date:  2021-01-23       Impact factor: 4.296

6.  Cardiomyopathy as presenting sign of glycogenin-1 deficiency-report of three cases and review of the literature.

Authors:  Carola Hedberg-Oldfors; Emma Glamuzina; Peter Ruygrok; Lisa J Anderson; Perry Elliott; Oliver Watkinson; Chris Occleshaw; Malcolm Abernathy; Clinton Turner; Nicola Kingston; Elaine Murphy; Anders Oldfors
Journal:  J Inherit Metab Dis       Date:  2016-10-07       Impact factor: 4.982

7.  Clinical heterogeneity and phenotype/genotype findings in 5 families with GYG1 deficiency.

Authors:  Rabah Ben Yaou; Aurélie Hubert; Isabelle Nelson; Julia R Dahlqvist; David Gaist; Nathalie Streichenberger; Maud Beuvin; Martin Krahn; Philippe Petiot; Frédéric Parisot; Fabrice Michel; Edoardo Malfatti; Norma Romero; Robert Yves Carlier; Bruno Eymard; Philippe Labrune; Morten Duno; Thomas Krag; Mathieu Cerino; Marc Bartoli; Gisèle Bonne; John Vissing; Pascal Laforet; François M Petit
Journal:  Neurol Genet       Date:  2017-12-18

8.  Glycogenin-1 deficiency mimicking limb-girdle muscular dystrophy.

Authors:  Claire Lefeuvre; Stéphane Schaeffer; Robert-Yves Carlier; Maxime Fournier; Françoise Chapon; Valérie Biancalana; Guillaume Nicolas; Edoardo Malfatti; Pascal Laforêt
Journal:  Mol Genet Metab Rep       Date:  2020-05-24

9.  Glycogenin is Dispensable for Glycogen Synthesis in Human Muscle, and Glycogenin Deficiency Causes Polyglucosan Storage.

Authors:  Kittichate Visuttijai; Carola Hedberg-Oldfors; Christer Thomsen; Emma Glamuzina; Cornelia Kornblum; Giorgio Tasca; Aurelio Hernandez-Lain; Joakim Sandstedt; Göran Dellgren; Peter Roach; Anders Oldfors
Journal:  J Clin Endocrinol Metab       Date:  2020-02-01       Impact factor: 5.958

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.